Top Clinical Trials companies in Finland by Return on Equity (ROE)
This ranking features the top 1 Clinical Trials companies in Finland ranked by Return on Equity (ROE), averaging a Return on Equity (ROE) of 19.64%, for February 07, 2025.
Finland
Clinical Trials
Return on Equity (ROE)
# |
Name |
Return on Equity (ROE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
19.64%
|
Dec. 31, 2023 | USD 3.15 | 0.25% |
|
Finland |
Frequently Asked Questions
-
Which Clinical Trials company in Finland has the highest Return on Equity (ROE) ?
The Clinical Trials company in Finland with the highest Return on Equity (ROE) is Biohit Oyj (Helsinki Stock Exchange: BIOBV.HE) at 19.64%.
-
Which Clinical Trials company in Finland has the lowest Return on Equity (ROE) ?
The Clinical Trials company in Finland with the lowest Return on Equity (ROE) is Biohit Oyj (Helsinki Stock Exchange: BIOBV.HE) at 19.64%.
-
What are the top 10 Clinical Trials companies in Finland by Return on Equity (ROE) ?
The top 10 Clinical Trials companies in Finland by Return on Equity (ROE) are and Biohit Oyj.
-
What are the bottom 10 Clinical Trials companies in Finland by Return on Equity (ROE) ?
The bottom 10 Clinical Trials companies in Finland by Return on Equity (ROE) are and Biohit Oyj.
